Indian cancer patients battle shortage of key drugs as platinum costs surgeCancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues a...
GSK in talks to buy cancer biotech Nuvalent for more than $9 billionBritish drug giant GSK is reportedly in talks to acquire cancer drugmaker Nuvalent. The deal could be worth over nine billion dollars. Disc...
US says BYD, Baidu and Alibaba and other tech giants are aiding China's militaryThe U.S. has updated its list of Chinese companies aiding Beijing's military, adding tech giants like Alibaba and Baidu, alongside chipmake...
Kiran Mazumdar-Shaw's Immuneel Therapeutics raises Rs 100 crore from Singularity AMC, Rainmatter, othersThe Bengaluru-based company makes CAR-T therapy, a form of cancer treatment where a patient’s own immune cells are taken out, trained in a ...
Team Europe to visit Assam on June 8-9 to launch India's first Blue Valley clusterGuwahati, Assam, is preparing to welcome a distinguished European Union delegation on June 8-9, as part of a mission to strengthen ties bet...
As AI shifts from training to inference, Intel moves up the stackIntel is changing its AI strategy. The company is now focusing on building complete AI systems and infrastructure, not just chips. This mov...
Govt sets up six sector groups to fast-track ‘Make in India 2.0’ pushIn a bold move towards self-sufficiency, India is ramping up its domestic manufacturing initiatives! Six government-led teams are tasked wi...
Govt sets up 6 sector-specific groups to identify products to boost manufacturing, cut importsIndia is boosting domestic manufacturing. Six expert groups will identify 100 products to reduce import dependence. This initiative aims to...
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
Concord Biotech shares jump 8% on USFDA nod for Mycophenolate Mofetil oral suspensionConcord Biotech shares saw a significant jump on Wednesday. This surge followed the company's announcement of receiving approval from the U...
Ahead of Market: 10 things that will decide stock market action on WednesdayIndian benchmark indices ended higher after a volatile session, with late buying in heavyweight IT stocks lifting sentiment. Sensex gained ...
Samsung minority union challenges bonus deal in courtA labour union representing several thousand Samsung Electronics employees asked a court on Tuesday to nullify a bonus agreement between th...
Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...
AI-Powered drug discovery could transform treatment development for Alzheimer’s, Parkinson’s and other brain disorders.Researchers are increasingly using AI to accelerate the search for treatments for neurological conditions such as Alzheimer’s, Parkinson’s,...
“Not Australia, but India rejected me for being a woman”: Kiran Mazumdar-Shaw clarifies how gender bias led her to build Biocon in viral postBiocon founder Kiran Mazumdar-Shaw intervened and clarified after a viral post claimed that Australia denied her a master brewer role due t...
Q-Line Biotec shares to list today. Check GMP ahead of debutQ-Line Biotech is poised for a strong stock market debut on Friday. Investor demand appears robust, with grey market trends showing a signi...
Failed NEET in 2016, built a career in the US by 2026: Woman reveals the roadmap that led to success when all felt lostAn Indian woman named Pragya Gupta has gone viral after sharing how her life changed 10 years after failing NEET. In an Instagram video, sh...